Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Spark Gap Technology for Lithotripsy

By HospiMedica staff writers
Posted on 09 Jun 2006
A new spark gap shockwave lithotripsy unit is designed for urologic purposes. More...


LithoGold, developed by Shockwave Technical Service (STS), the urology division of Tissue Regeneration Technologies (Woodstock, GA, USA), is a new electrohydraulic (spark gap) shockwave lithotripsy unit that incorporates the STS SmartTrodeintelligent electrode, which automatically adjusts itself for the specified energy level.

The unit is built into the housing of the Siemens Medical Solutions (Erlangen, Germany) Modularis system, and thus is compatible with the Modularis table and choice of Siemens' C-arms. As a result, the Modularis platform will be available with either electromagnetic or spark gap shockwave technology. The system was unveiled at the annual meeting of the American Urological Association in May 2006 in Atlanta (GA, USA).

The Modularis system, based on electromagnetic shockwave technology, will be marketed and sold by Siemens, whereas the platform with spark gap shockwave technology will be exclusively marketed and sold by STS. The system is not yet commercially available in the United States, pending review by the U.S. Food and Drug Administration (FDA).

"We were very pleased when STS approached us to build a partnership to integrate their spark gap technology into our Modularis components, said Roby Trierweiler, senior director of the surgery and urology special systems division at Siemens Medical Solutions.

"Using the Modularis components from Siemens helped to dramatically reduce development time of the LithoGold, said John Warlick, president, STS. "Now we can provide not only a powerful lithotripsy system, but a comprehensive urology solution.



Related Links:
Tissue Regeneration Technologies
Siemens Medical Solutions

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.